4-5 pages

Outline

Trastuzumab Deruxtecan and Patient with HER2-Positive Breast Cancer

1. Introduction: [Introduce Trastuzumab Deruxtecan and its role in contributing to HER2-

Positive Breast Cancer, basic information of breast cancer, and explain why I am

interested in this topic or why it is important. (back up with epidemiologic data)

2. Subheading 1 – Major advantages of Trastuzumab Deruxtecan: [Discuss the main

pharmacological issues]

3. Subheading 2 – Major disadvantage of Trastuzumab Deruxtecan: Discuss

pharmacological issues) (I will look up for more biological data to back up my

statement).]

4. Subheading 3 – Consideration on Trastuzumab Deruxtecan for HER2-positive breast

cancer patients: [Discuss epidemiologic evidence, Discuss clinical use.

5. Conclusion: [Final take-home messages, briefly summarize major findings of review on

the effects of Trastuzumab Deruxtecan and HER2-positive breast cancer.

Tables: [Table summarizing the studies of the association between Trastuzumab Deruxtecan for

HER2-positive breast cancer patients.